Pricing Log in Create free account

Vera Therapeutics, Inc. (VERA) vs Zymeworks Inc. (ZYME)

Vera Therapeutics, Inc. and Zymeworks Inc. are both Biotechnology companies. Vera Therapeutics, Inc. and Zymeworks Inc. are of similar size ($2.2B and $2.0B). Vera Therapeutics, Inc. has the higher net margin (0.00% vs −404.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Vera Therapeutics, Inc. leads on 7 and Zymeworks Inc. on 6.

Valuation

Metric VERA ZYME Biotechnology median
P/E n/m n/m 10.26
P/S n/m 56.80 9.18
P/B 5.34 26.24 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 49.52 8.98
Earnings yield (19.32%) (6.99%) (34.89%)
Free cash flow yield (15.55%) (5.76%) (24.52%)

Profitability

Metric VERA ZYME Biotechnology median
Gross margin 0.00% (246.66%) 65.16%
Operating margin 0.00% (418.99%) 0.00%
Net margin 0.00% (404.00%) 0.00%
Free cash flow margin 0.00% (324.68%) 0.00%
Return on equity (91.75%) (72.31%) (50.12%)
Return on assets (72.32%) (37.25%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric VERA ZYME Biotechnology median
Revenue growth (TTM) — (69.78%) 6.26%
EPS growth (last fiscal year) (69.45%) 33.33% 29.88%
Revenue growth, 5-year CAGR — 22.16% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric VERA ZYME Biotechnology median
Debt to equity 0.18 0.00 0.00
Current ratio 10.92 6.32 4.89
Net debt to EBITDA 2.00 2.81 1.01

Dividend

Metric VERA ZYME Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric VERA ZYME Biotechnology median
Market cap 2.17b 2.04b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack